These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 4364363)

  • 21. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO
    Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
    [No Abstract]   [Full Text] [Related]  

  • 22. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.
    Cerottini JC; Brunner KT
    Adv Immunol; 1974; 18():67-132. PubMed ID: 4151339
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytotoxicity against tumour-associated antigens not H-2 restricted.
    Holden HT; Herberman RB
    Nature; 1977 Jul; 268(5617):250-2. PubMed ID: 69992
    [No Abstract]   [Full Text] [Related]  

  • 24. LD-SD interaction in vivo and the allograft reaction.
    van Rood JJ
    Transplant Proc; 1973 Dec; 5(4):1747-50. PubMed ID: 4272829
    [No Abstract]   [Full Text] [Related]  

  • 25. The immunologic response to xenografts. Recognition of mouse H-2 histocompatibility antigens by the rat.
    Sachs DH; Winn HJ; Russell PS
    J Immunol; 1971 Aug; 107(2):481-92. PubMed ID: 4936290
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic alterations in tumor cells resulting in their escape from the immune response.
    Hyman R
    Cancer Chemother Rep; 1974; 58(4):431-9. PubMed ID: 4136747
    [No Abstract]   [Full Text] [Related]  

  • 27. Cell-mediated immunity and blocking antibodies to renal allografts.
    Hellström I; Hellström KE
    Transplant Proc; 1972 Sep; 4(3):369-71. PubMed ID: 4562764
    [No Abstract]   [Full Text] [Related]  

  • 28. An analysis of variables affecting the measurement of tumor immunity in vitro with 125I-iododeoxyuridine-labelled target cells. Studies of immunity to primary Moloney sarcomas.
    Seeger RC; Rayner SA; Owen JJ
    Int J Cancer; 1974 May; 13(5):697-713. PubMed ID: 4367342
    [No Abstract]   [Full Text] [Related]  

  • 29. Emergence of foreign H-2-like cytotoxicity and transplantation targets on vaccinia and Moloney virus-infected Meth. A tumour cells.
    Matossian-Rogers A; Garrido F; Festenstein H
    Scand J Immunol; 1977; 6(5):541-6. PubMed ID: 142300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic or antgonistic effect of different antibody concentrations on in vitro lymphocyte cytotoxicity in the Moloney sarcoma virus system.
    Skurzak HM; Klein E; Yoshida TO; Lamon EW
    J Exp Med; 1972 Apr; 135(4):997-1002. PubMed ID: 5018057
    [No Abstract]   [Full Text] [Related]  

  • 31. On the relationship between initiator and effector cells in the response to major tansplantation antigens.
    Howard JC
    Transplant Proc; 1973 Dec; 5(4):1451-6. PubMed ID: 4130057
    [No Abstract]   [Full Text] [Related]  

  • 32. Spontaneous disappearance of tumorigenicity in a polyoma virus-induced neoplasm carried in vitro.
    Cohen JM; Law LW
    Proc Soc Exp Biol Med; 1974 Feb; 145(2):385-8. PubMed ID: 4360637
    [No Abstract]   [Full Text] [Related]  

  • 33. Allograft reaction against H-2-region antigens.
    Klein J
    Transplant Proc; 1977 Mar; 9(1):847-52. PubMed ID: 17202
    [No Abstract]   [Full Text] [Related]  

  • 34. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of blocking serum factors in organ grafted rats.
    Heron I; Sorensen SF
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Oct; 81(5):606-14. PubMed ID: 4134373
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumor-associated membrane antigens and the antitumor immune reactions.
    Levy JP; Kourilsky FM
    Transplant Proc; 1973 Dec; 5(4):1435-40. PubMed ID: 4130056
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunologic enhancement of normal tissue grafts.
    Feldman JD
    Pathol Annu; 1972; 7():19-44. PubMed ID: 4114602
    [No Abstract]   [Full Text] [Related]  

  • 39. Humoral factors. Immunologic enhancement.
    Batchelor JR; Welsh KI; Burgos H
    Transplant Proc; 1977 Mar; 9(1):931-6. PubMed ID: 141143
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumor specific antigens in viral neoplasms and in unrelated virus infected tumors.
    Sjögren HO
    Ann Med Exp Biol Fenn; 1966; 44(2):227-31. PubMed ID: 4290659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.